Renaze, France

Anaïs Fournial

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Pierre Fabre Medicament, Université Paris-Sud 11. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anaïs Fournial. Retrieved from https://idiyas.com/inventor/anaïs-fournial

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anaïs Fournial

Introduction

Anaïs Fournial is a notable inventor based in Renaze, France. He has made significant contributions to the field of anti-cancer therapy through his innovative research and development. His work focuses on the creation of dimeric derivatives of artemisinin, which have promising applications in cancer treatment.

Latest Patents

Fournial holds a patent for "Dimeric derivatives of artemisinin and application in anti-cancer therapy." This invention relates to dimeric derivatives of 10-trifluoromethylated artemisinin, along with their pharmaceutically acceptable salts. The patent also details the preparation methods and various uses of these derivatives, particularly in the treatment of cancer.

Career Highlights

Throughout his career, Fournial has worked with esteemed organizations such as Pierre Fabre Medicament and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to significant developments in pharmaceutical sciences.

Collaborations

Fournial has collaborated with notable professionals in his field, including Jean-Pierre Begue and Danièle Bonnet-Delpon. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Anaïs Fournial's innovative work in developing anti-cancer therapies showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight the importance of research in combating serious health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…